ICU severity of illness scores: APACHE, SAPS and MPM.
Jorge I F Salluh, Márcio Soares
https://pubmed.ncbi.nlm.nih.gov/25137401Actively Recruiting
Led by University of Pernambuco · Updated on 2026-01-09
30
Participants Needed
1
Research Sites
N/A
Total Duration
U
University of Pernambuco
Lead Sponsor
U
Universidade Federal de Pernambuco
Collaborating Sponsor
This research aims to understand how different body positions affect breathing effort, lung ventilation, and air distribution in critically ill adults who are on mechanical ventilation. It focuses on assessing the effects of Automatic Lateralization Therapy on respiratory drive and lung function compared to standard supine positioning. The study also evaluates whether combining this therapy with Flow Bias enhances respiratory and functional outcomes. The study is a quasi-experimental, non-randomized physiological intervention conducted in an ICU setting.
CONDITIONS
Body Lateralization and Its Effects on Respiratory Drive, Ventilation, and Pulmonary Aeration in Critically Ill Patients
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Unilateral: 140 minutes (2 hours 20 minutes); Bilateral: 370 minutes (6 hours 10 minutes)
Participants undergo body positioning interventions including supine positioning with head elevation and automatic lateralization therapy with progressive body tilt angles. These interventions aim to evaluate respiratory drive activation, ventilation, and pulmonary aeration while being monitored for safety.
1 continuous intervention session per participant
Total: 1 location
1
Hospital Geral Otávio de Freitas - Secretaria de Saúde de Pernambuco
Recife, Pernamu, Brazil, 50670-901
Actively Recruiting
S
Shirley Lima Campos, PhD
E
Emanuel Fernandes Ferreira da Silva Júnior, MSc
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
NON_RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Jorge I F Salluh, Márcio Soares
https://pubmed.ncbi.nlm.nih.gov/25137401Jose Dianti, Michele Bertoni, Ewan C Goligher
https://pubmed.ncbi.nlm.nih.gov/32623476Hui Chen, Meihao Liang, Yuanchao He...
https://pubmed.ncbi.nlm.nih.gov/37592166Emanuel Fernandes Ferreira da Silva Junior, Shirley Lima Campos, Wagner Souza Leite...
https://pubmed.ncbi.nlm.nih.gov/37104255Layane S P Costa, Cyda M A Reinaux, Emanuel F F Silva Júnior...
https://pubmed.ncbi.nlm.nih.gov/41166369Michael B Zack
https://pubmed.ncbi.nlm.nih.gov/19136401Meryl Vedrenne-Cloquet, Y Ito, J Hotz...
https://pubmed.ncbi.nlm.nih.gov/39367452Michele Umbrello, Paolo Formenti, Daniela Longhi...
https://pubmed.ncbi.nlm.nih.gov/25886857Karn Suttapanit, Supawit Wongkrasunt, Sorravit Savatmongkorngul...
https://pubmed.ncbi.nlm.nih.gov/37726832Gioacchino Schifino, Maria L Vega, Lara Pisani...
https://pubmed.ncbi.nlm.nih.gov/35483993